Yes, a 19-year-old can receive the second dose of Bexsero today, even though it's 3 years late.
Complete the 2-dose series now—there is no need to restart the series, and the delayed interval does not invalidate the first dose. The patient should receive one dose today to complete their vaccination series 1, 2.
Key Points About Delayed Dosing
No Maximum Interval Exists
- CDC/ACIP guidelines and FDA labeling do not specify a maximum interval between Bexsero doses
- The general vaccine principle applies: an interrupted series does not need to be restarted—just continue where you left off 1
- The minimum interval between doses is 4 weeks, but there is no upper limit mentioned in any guidance 1
Current Dosing Recommendations
The updated 2024 ACIP recommendations for Bexsero (MenB-4C) now align with a 0 and 6-month schedule for healthy adolescents/young adults aged 16-23 years 3. However, this patient:
- Started their series at age 16 (3 years ago)
- Is now 19 years old
- Still falls within the licensed age range (10-25 years) 4, 2
- Simply needs to complete what they started
What Happens After a Long Delay
Research shows that even after extended intervals:
- Antibody levels decline over time but remain detectable 5
- A booster dose (which is essentially what this delayed second dose represents) produces a robust immune response 5
- Studies demonstrate that individuals vaccinated years earlier show strong anamnestic responses when re-exposed to the vaccine 5
Clinical Approach
Administer one dose of Bexsero (MenB-4C) today to complete the 2-dose series.
Important Caveats
- Do not switch vaccine products: If the first dose was Bexsero (MenB-4C), the second dose must also be Bexsero—the two MenB vaccines are not interchangeable 1, 2
- Verify which MenB vaccine was given 3 years ago (Bexsero vs. Trumenba) before proceeding
- The patient remains within the licensed age range (up to 25 years) 4, 2
Why This Works
The 3-year gap, while longer than ideal, does not negate the immunologic priming from the first dose. The immune system retains memory B cells that will respond to the second dose, producing protective antibodies 5. This is fundamentally different from starting over—the first dose established immunologic memory that persists despite the time elapsed.